Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1933379
Max Phase: Preclinical
Molecular Formula: C64H114N22O18
Molecular Weight: 1479.75
Molecule Type: Small molecule
Associated Items:
ID: ALA1933379
Max Phase: Preclinical
Molecular Formula: C64H114N22O18
Molecular Weight: 1479.75
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: N=C(N)NCCC[C@@H]1NC(=O)[C@H]2CCCC[C@@H]2NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]2CCCC[C@@H]2NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC1=O
Standard InChI: InChI=1S/C64H114N22O18/c65-25-9-5-19-39-53(95)81-41(21-7-11-27-67)58(100)86-48(34-88)62(104)84-46(32-50(91)92)60(102)76-38-18-4-2-16-36(38)52(94)78-44(24-14-30-74-64(71)72)56(98)80-40(20-6-10-26-66)54(96)82-42(22-8-12-28-68)57(99)85-47(33-87)61(103)83-45(31-49(89)90)59(101)75-37-17-3-1-15-35(37)51(93)77-43(55(97)79-39)23-13-29-73-63(69)70/h35-48,87-88H,1-34,65-68H2,(H,75,101)(H,76,102)(H,77,93)(H,78,94)(H,79,97)(H,80,98)(H,81,95)(H,82,96)(H,83,103)(H,84,104)(H,85,99)(H,86,100)(H,89,90)(H,91,92)(H4,69,70,73)(H4,71,72,74)/t35-,36-,37-,38-,39-,40-,41-,42-,43-,44-,45-,46-,47-,48-/m0/s1
Standard InChI Key: XFINVMWOBVFEMM-PFMJJPHGSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1479.75 | Molecular Weight (Monoisotopic): 1478.8681 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Baeza JL, de la Torre BG, Santiveri CM, Almeida RD, García-López MT, Gerona-Navarro G, Jaffrey SR, Jiménez MÁ, Andreu D, González-Muñiz R, Martín-Martínez M.. (2012) Cyclic amino acid linkers stabilizing key loops of brain derived neurotrophic factor., 22 (1): [PMID:22119467] [10.1016/j.bmcl.2011.10.107] |
Source(1):